GlassScriptPhysician profile
Gaspar Msangi
NPI 1043467038
$11,356.49
in general payments reported to CMS, 2019-2025
31 companies · $2,633 in 2025
The $2,633 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,432 · 2020: $669 · 2021: $1,066 · 2022: $2,048 · 2023: $1,655 · 2024: $854 · 2025: $2,633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,848 · Travel and Lodging: $2,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,847.50 |
| Travel and Lodging | $2,294.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $7,906.47 | 2019-2025 | Titan, Coloplast Tfl Drive, Vortek Hydro |
| Medtronic, INC. | $1,140.31 | 2022-2025 | Interstim |
| Boston Scientific Corporation | $496.38 | 2019-2025 | Axonics, Lithocatch, Lithovue |
| Janssen Biotech, INC. | $319.67 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $233.96 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $168.39 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $107.91 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $91.85 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $74.20 | 2019-2021 | |
| Myovant Sciences INC. | $73.95 | 2021-2022 | |
| Teleflex LLC | $71.51 | 2023-2025 | Urolift, Barrigel |
| C. R. Bard, INC. & Subsidiaries | $69.13 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Stryker Corporation | $65.71 | 2024 | 1788 |
| Endo USA, INC. | $54.82 | 2024-2025 | Xiaflex, Aveed |
| Innovation Technologies INC | $49.11 | 2022-2025 | Irrisept |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $47.29 | 2019-2021 | |
| Abbvie INC. | $42.25 | 2020-2025 | |
| Ferring Pharmaceuticals INC. | $35.40 | 2019 | |
| Laborie Medical Technologies Corp. | $34.75 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Zyla Life Sciences, INC. | $34.07 | 2019-2020 | |
| 180 Medical, INC. | $27.41 | 2021 | |
| Telix Pharmaceuticals | $25.55 | 2025 | Illuccix |
| Travere Therapeutics, INC. | $25.07 | 2019-2021 | |
| Sagent Pharmaceuticals | $24.89 | 2024 | Glydo |
| Convatec INC. | $24.00 | 2022 | |
| Procept Biorobotics Corporation | $23.46 | 2023 | Aquabeam Robotic System |
| Urovant Sciences INC | $20.47 | 2022 | |
| Biocompatibles, INC. | $20.08 | 2019 | |
| Rochester Medical Corporation | $17.05 | 2020 | |
| Olympus America INC. | $16.70 | 2024 | Itind System |
| Integra Lifesciences Corporation | $14.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaspar Msangi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.